2025-04-08 18:22:54
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Supriya Lifescience Ltd Q2 FY2023 profit falls to Rs. 16.86 crores
Posted On : 2022-11-12 22:42:11( TIMEZONE : IST )
Supriya Lifescience Limited has reported Standalone financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 114.777 crores during the period ended September 30, 2022 as compared to Rs. 103.712 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 16.862 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 25.249 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 2.10 for the period ended September 30, 2022 as compared to Rs. 3.14 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 114.777 crs | ₹103.712 crs |  10.67% |
| Net Profit | ₹16.862 crs | ₹25.249 crs |  -33.22% |
| EPS | ₹2.10 | ₹3.14 | -33.12% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 114.777 crores during the period ended September 30, 2022 as compared to Rs.151.180 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.16.862 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.58.22 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.2.10 for the period ended September 30, 2022 as compared to Rs.7.96 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 114.777 crs | ₹151.180 crs | -24.08% |
| Net Profit | ₹16.862 crs | ₹58.22 crs | -71.04% |
| EPS | ₹2.10 | ₹7.96 | -73.62% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.218.489 crores during the 6 Months period ended September 30, 2022 as compared to Rs.230.061 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.42.111 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.65.959 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.5.23 for the 6 Months period ended September 30, 2022 as compared to Rs.9.01 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹218.489 crs | ₹230.061 crs | -5.03% |
| Net Profit | ₹42.111 crs | ₹65.959 crs | -36.16% |
| EPS | ₹5.23 | ₹9.01 | -41.95% |
Shares of Supriya Lifescience Limited was last trading in BSE at Rs. 250.85 as compared to the previous close of Rs. 260.90. The total number of shares traded during the day was 99620 in over 4869 trades.
The stock hit an intraday high of Rs. 255.95 and intraday low of 240.65. The net turnover during the day was Rs. 24949374.00.
